LRpath

LRpath performs gene set enrichment (GSE) testing on RNA-sequencing (RNA-seq) data to identify over- and under-represented biological functions while adjusting for expression- and transcript-related biases.


Key Features:

  • RNA-Enrich: Empirically adjusts for average read count per gene to mitigate biases associated with longer and highly-expressed transcripts.
  • Logistic regression framework: Applies logistic regression to continuous gene-level statistics without requiring a P-value cutoff, preserving information for downstream GSE analysis.
  • Bias correction: Improves type I error rate and detection power in gene set enrichment testing by accounting for average read count per gene.
  • Flexibility: Operates without a P-value threshold, accommodating various experimental designs and small sample-sized RNA-seq experiments.
  • Annotation support: Supports 16 different gene annotation databases for enrichment analysis.

Scientific Applications:

  • GSE analysis of RNA-seq differential expression: Identification of over- or under-represented biological functions from RNA-seq differential expression results.
  • Small-sample RNA-seq studies: Enrichment testing in experiments with limited sample sizes where preserving continuous gene-level information is advantageous.

Methodology:

Uses the RNA-Enrich empirical adjustment for average read count per gene and performs logistic regression on continuous gene-level statistics without applying a P-value cutoff.

Topics

Details

Tool Type:
web application
Operating Systems:
Linux, Windows, Mac
Programming Languages:
R
Added:
8/3/2017
Last Updated:
11/24/2024

Operations

Data Inputs & Outputs

Regression analysis

Outputs

    Other operations do not define inputs or outputs.

    Publications

    Lee C, Patil S, Sartor MA. RNA-Enrich: a cut-off free functional enrichment testing method for RNA-seq with improved detection power. Bioinformatics. 2015;32(7):1100-1102. doi:10.1093/bioinformatics/btv694. PMID:26607492. PMCID:PMC5860544.

    PMID: 26607492
    PMCID: PMC5860544
    Funding: - National Institutes of Health: P30ES017885-01 and R01CA158286-01

    Documentation

    Links